SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-183997
Filing Date
2020-06-30
Accepted
2020-06-30 16:01:44
Documents
3
Period of Report
2020-06-30
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d939176d8k.htm 8-K 20006
2 EX-3.1 d939176dex31.htm EX-3.1 24895
3 EX-3.2 d939176dex32.htm EX-3.2 185950
  Complete submission text file 0001193125-20-183997.txt   232002
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39344 | Film No.: 201002319
SIC: 2836 Biological Products, (No Diagnostic Substances)